The biggest IPO in history is about to reach another milestone, but smart investors shouldn’t confuse forced buying with ...
Anti-vascular endothelial growth factor (VEGF) agents in combination with immunotherapies have improved outcomes for cancer patients, but predictive biomarkers have not been elucidated. We report here ...